智通财经APP讯，瀛晟科学(00209)公布，于2026年1月8日(星期四)下午四时正(即接纳供股股份及缴付股款以及申请额外供股股份及缴付股款的最后时限)，合共12份有关约10.39亿股供股股份的有效接纳及申请已获接纳及申请，占供股项下可供认购的约13亿股供股股份总数约79.92%。 因此，供股出现认购不足，约2.61亿股供股股份未获认购，占供股项下可供认购的约13亿股供股股份总数约20.08%。
由于供股股份认购不足，且根据包销协议，包销商已促使认购人认购合共约2.61亿股供股股份，占供股项下可供认购的约13亿股供股股份总数约20.08%。经包销商促使的认购人认购后，供股项下可供认购的合共约13亿股供股股份已获悉数认购。
供股所得款项总额约为1.82亿港元，而扣除包销佣金及供股产生的所有其他相关开支后，供股所得款项净额估计约为1.765亿港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.